Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Staffan EncrantzDirector | Sight SciencesSGHT | Open-market buy | 06/10 | 06/11 | 14,100 sh | $4.88 | $68,808 | +1.0% |
Sight SciencesSGHT | Open-market sale10b5-1 plan | 05/18 | 05/19 | 12,728 sh | $5.12 | $65,167.36 | −1.8% | |
Hayden Jeremy B.Chief Legal Officer | Sight SciencesSGHT | Open-market sale10b5-1 plan | 04/06 | 04/09 | 13,761 sh | $3.55 | $48,851.55 | −3.6% |
Sight SciencesSGHT | Open-market sale10b5-1 plan | 04/06 | 04/09 | 7,231 sh | $3.55 | $25,670.05 | −3.0% | |
Sight SciencesSGHT | Open-market sale10b5-1 plan | 04/02 | 04/03 | 25,874 sh | $3.48 | $90,041.52 | −3.6% | |
Badawi DavidCTO | Sight SciencesSGHT | Open-market sale10b5-1 plan | 04/02 | 04/03 | 8,168 sh | $3.48 | $28,424.64 | −0.4% |
Brenton TaylorEVP, Operations & R&D | Sight SciencesSGHT | Open-market sale10b5-1 plan | 04/01 | 04/03 | 2,869 sh | $3.70 | $10,615.3 | −1.1% |
Badawi PaulPresident and CEO | Sight SciencesSGHT | Open-market sale10b5-1 plan | 04/01 | 04/03 | 29,244 sh | $3.70 | $108,202.8 | −0.5% |
Hayden Jeremy B.Chief Legal Officer | Sight SciencesSGHT | Open-market sale10b5-1 plan | 01/16 | 01/21 | 6,308 sh | $6.62 | $41,758.96 | −2.3% |
Badawi DavidCTO | Sight SciencesSGHT | Open-market sale10b5-1 plan | 01/16 | 01/21 | 4,836 sh | $6.62 | $32,014.32 | −0.3% |
Badawi PaulPresident and CEO | Sight SciencesSGHT | Open-market sale10b5-1 plan | 01/16 | 01/21 | 22,362 sh | $6.62 | $148,036.44 | −0.4% |
Sight SciencesSGHT | Open-market sale10b5-1 plan | 01/16 | 01/21 | 2,616 sh | $6.62 | $17,317.92 | −1.7% | |
Sight SciencesSGHT | Open-market sale | 01/05–01/06 | 01/06 | 20,543 sh2 trades | $7.66avg. | $157,366.28 | −3.3% | |
Brenton TaylorEVP, Operations & R&D | Sight SciencesSGHT | Open-market sale | 01/06 | 01/06 | 619 sh | $7.48 | $4,630.12 | −0.4% |
Sight SciencesSGHT | Open-market sale10b5-1 plan | 01/05–01/06 | 01/06 | 11,170 sh2 trades | $7.77avg. | $86,742.5 | −4.4% | |
Sight SciencesSGHT | Open-market sale | 01/02–01/06 | 01/06 | 9,660 sh3 trades | $7.57avg. | $73,148.44 | −0.5% | |
Sight SciencesSGHT | Open-market sale | 01/02–01/06 | 01/06 | 37,226 sh2 trades | $7.45avg. | $277,182.68 | −0.6% | |
Sight SciencesSGHT | Open-market sale | 01/05–01/06 | 01/06 | 4,999 sh2 trades | $7.78avg. | $38,890.22 | −3.1% | |
Staffan EncrantzDirector | Sight SciencesSGHT | Open-market buy | 25/12/16 | 25/12/18 | 13,958 sh | $8.31 | $115,990.98 | +1.0% |
Sight SciencesSGHT | Open-market sale | 25/12/02 | 25/12/03 | 2,518 sh | $8.25 | $20,773.5 | −1.6% |